Strategic summary - proposed merger with InfreaThe Boards of Netel and Infrea have jointly announced their intention to merge the companies, with Netel as the absorbing party. The completion of the me ...
Gubra's collaboration partner Hemab will present preclinical results from the HMB-003 program on July 11, 2026, at the ISTH Congress in Paris. The preclinical data show that ...